English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

.. Objectives: To determine incidence of steatosis in non-responder cases of chronic HCV. Study Design: Cross-sectional study. Setting: Tertiary Care Sanatorium in Medicine Department of LIAQUAT University Hospital Hyderabad/Jamshoro. Period: 26-9-2011 to 25 August 2012. Material & Methods: Total 144 non-responders cases of Hepatitis C were integrated. Both gender, age 18 to 50 yrs, chronic HCV non-responder cases as well as cases fit for hepatic biopsy were integrated in study. Grading of Inflammation was carried out as indicated by histopathological measures. Results: Mean age was 48.5 + 5.2years. Uppermost prevalence of chronic HCV disease was 65(45.13%) at 41 to 50 years age interval whereas 42(29.1%) cases were noticed in 31 to 40 yrs age group and 25(17.3%) cases were observed in 20 to 30 years of young age group. In this study hepatic steatosis occurrence was observed in 103 (71.5%) cases and these were categories as: grade 1, grade 2, grade 3, as (<33%) 45/103(43.68%), (33 to 66%) 35/103(33.98%), (>66%) 23/103(22.33%) respectively. Conclusion: Hepatic steatosis is a important risk factor the cases of HCV to decreased response to antiviral therapy and for progression toward fibrosis as observed in cases related to metabolic steatosis.

HEPATITIS “C”; FREQUENCY OF HEPATIC STEATOSIS IN NON RESPONDER PATIENTS